Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5′-deoxy-5-fluorouridine as adjuvant chemotherapy

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 479-482

  Nishimura, Genichi ^a   Terada, Itsurou ^a   Kobayashi, Takashi ^a   Ninomiya, Itasu ^a   Kitagawa, Hirohisa ^a   Fushida, Sachio ^a   Fujimura, Takashi ^a   Kayahara, Masato ^a   Shimizu, Koichi ^a   Ohta, Tetsuo ^a   Miwa, Koichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

5 DFUR; Dihydropyrimidine dehydrogenase; Thymidine phosphorylase

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DIHYDROPYRIMIDINE DEHYDROGENASE; DOXIFLURIDINE; DRUG DERIVATIVE; FLOXURIDINE; OXIDOREDUCTASE; THYMIDINE PHOSPHORYLASE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; HUMAN; MORTALITY; RECURRENT DISEASE; TIME;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DIHYDROURACIL DEHYDROGENASE (NADP); DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOXURIDINE; HUMANS; OXIDOREDUCTASES; RECURRENCE; THYMIDINE PHOSPHORYLASE; TIME FACTORS;

EID: 0036582566     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.3.479     Document Type: Article

References (13)

1. Heggie GD, Sommadossi JP, Gross DS, Huster WJ and Diasio RB: Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res 47: 2203-2206, 1987. (Pubitemid 17074634)
2. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N and Milano G: A role or dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur J Cancer 30A: 1517-1522, 1994. (Pubitemid 24343014)
3. Nita ME, Tominaga O, Nagawa H, Tsuruo T and Muto T: Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Hepatogastroenterology 45: 2117-2122.
4. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takeuchi T, Okabe H and Fukushima M: Dihydropyrimidine dehydrogenase activity and messenger RNA levels may be related to the anti-tumor effects of 5-fluorouracil on human tumor xenografts in nude mice. Clin Cancer Res 5: 883-889, 1999.
5. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T and Ishitsuka H: Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407-1411, 1996. (Pubitemid 26403242)
6. Mori K, Hasegawa M, Nishida M, et al: Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tissues. Int J Oncol 17: 33-38, 2000.
7. Mamounas E, Wieand S, Wolmark N, et al: Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four national surgical adjuvant breast and bowel project adjuvant studies CC-01. C-02, C-03 andC-04). J Clin Oncol 17: 1349-1355, 1999. (Pubitemid 29220839)
8. The Meta-analysis Group in Cancer: Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301-308, 1998.
9. Petrelli N, Herrera L, Rustum Y, et al: A randomized trial of 5-fluorouracil versus 5-fluorouracil and high dose leucovin versus 5-fluorouracil and methotrexate in previous untreated patients with colorectal carcinoma. J Clin Oncol 10: 1559-1565, 1987. (Pubitemid 18010132)
10. Poon MA, O'Connel MJ, Moertel CG, el al: Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7: 1407-1418, 1989. (Pubitemid 19245110)
11. IMPACT Trial: Efficacy of adjuvant fluorouracil and folic acid in colorectal cancer. Lancet 345: 939-944, 1995.
12. Yamamoto Y, Toi M and Tominaga T: Prediction of the effect of 5′-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients. Oncol Rep 3: 863-965, 1996.
13. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N and Ishitsuka H: Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58: 685-690, 1998. (Pubitemid 28099478)